NYSE:EVH

Evolent Health Stock Forecast, Price & News

$20.16
-0.46 (-2.23 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.04
Now: $20.16
$20.97
50-Day Range
$18.33
MA: $20.13
$21.22
52-Week Range
$5.22
Now: $20.16
$22.35
Volume273,947 shs
Average Volume579,676 shs
Market Capitalization$1.74 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.4
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Evolent Health logo

Industry, Sector and Symbol

Industry Management services
Sub-IndustryN/A
CUSIPN/A
Phone571-389-6000
Employees2,900
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$846.38 million
Cash Flow$2.80 per share
Book Value$10.98 per share

Profitability

Net Income$-301,970,000.00

Miscellaneous

Market Cap$1.74 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

Headlines

EVH Apr 2021 22.500 call
March 22, 2021 |  ca.finance.yahoo.com
EVH Jun 2021 20.000 call
March 22, 2021 |  ca.finance.yahoo.com
EVH Sep 2021 17.500 call
March 22, 2021 |  ca.finance.yahoo.com
EVH Apr 2021 15.000 call
March 22, 2021 |  ca.finance.yahoo.com
EVH Mar 2021 12.500 call
March 20, 2021 |  finance.yahoo.com
Evolent Health (EVH) Q4 2020 Earnings Call Transcript
March 7, 2021 |  finance.yahoo.com
Evolent Health EPS beats by $0.04, beats on revenue
February 26, 2021 |  seekingalpha.com
Why Evolent Health Stock Is Jumping Today
February 26, 2021 |  finance.yahoo.com
Evolent Health Announces Fourth Quarter and Full Year 2020 Results
February 25, 2021 |  markets.businessinsider.com
Earnings Preview: Evolent Health
February 24, 2021 |  finance.yahoo.com
EVH Mar 2021 15.000 call
January 28, 2021 |  finance.yahoo.com
Is Evolent Health (NYSE:EVH) Weighed On By Its Debt Load?
January 27, 2021 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

1.22 out of 5 stars

Computer And Technology Sector

536th out of 1,551 stocks

Management Services Industry

6th out of 12 stocks

Analyst Opinion: 1.4Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
$20.16
-0.46 (-2.23 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Evolent Health (NYSE:EVH) Frequently Asked Questions

Is Evolent Health a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Evolent Health stock.
View analyst ratings for Evolent Health
or view top-rated stocks.

What stocks does MarketBeat like better than Evolent Health?

Wall Street analysts have given Evolent Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Evolent Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Evolent Health
.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) announced its earnings results on Thursday, February, 25th. The technology company reported ($0.01) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.10) by $0.09. The technology company had revenue of $271.92 million for the quarter, compared to analysts' expectations of $257.60 million. Evolent Health had a negative trailing twelve-month return on equity of 4.40% and a negative net margin of 52.35%.
View Evolent Health's earnings history
.

How has Evolent Health's stock been impacted by Coronavirus (COVID-19)?

Evolent Health's stock was trading at $6.92 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, EVH shares have increased by 191.3% and is now trading at $20.16.
View which stocks have been most impacted by COVID-19
.

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its FY 2021 After-Hours earnings guidance on Thursday, February, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $830-880 million, compared to the consensus revenue estimate of $940.38 million.

What price target have analysts set for EVH?

10 brokerages have issued 12-month price objectives for Evolent Health's stock. Their forecasts range from $8.00 to $27.00. On average, they anticipate Evolent Health's stock price to reach $18.00 in the next year. This suggests that the stock has a possible downside of 10.7%.
View analysts' price targets for Evolent Health
or view top-rated stocks among Wall Street analysts.

Who are Evolent Health's key executives?

Evolent Health's management team includes the following people:
  • Mr. Frank John Williams, Co-Founder & Exec. Chairman (Age 55, Pay $903k)
  • Mr. Seth Barrie Blackley, Co-Founder, CEO & Director (Age 42, Pay $652.67k)
  • Mr. John Paul Johnson, Chief Financial Officer (Age 37, Pay $451.67k)
  • Mr. Jonathan David Weinberg, Chief Legal Officer, Gen. Counsel & Sec. (Age 53, Pay $652.33k)
  • Dr. Norman C. Payson, Advisor (Age 72, Pay $200k)
  • Mr. Steve Tutewohl, Chief Operating Officer (Age 49)
  • Mr. Aammaad Shams, Interim Principal Accounting Officer & Corp. Controller (Age 37)
  • Mr. Bob East, Investor Contact
  • Ms. Jordan Flynn, VP & Chief Compliance Officer
  • Ms. Jessica Somers, Sr. VP of Corp. Devel.

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health CEO Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among Evolent Health's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Evolent Health's key competitors?

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a number of retail and institutional investors. Top institutional investors include First Midwest Bank Trust Division (0.05%) and Harbor Investment Advisory LLC (0.00%). Company insiders that own Evolent Health stock include Doug S Aron, Jonathan Weinberg, Kenneth A Samet, Michael D'amato and Seth Blackley.
View institutional ownership trends for Evolent Health
.

Which major investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Harbor Investment Advisory LLC.
View insider buying and selling activity for Evolent Health
or view top insider-selling stocks.

Which major investors are buying Evolent Health stock?

EVH stock was bought by a variety of institutional investors in the last quarter, including First Midwest Bank Trust Division. Company insiders that have bought Evolent Health stock in the last two years include Doug S Aron, Kenneth A Samet, Michael D'amato, and Seth Blackley.
View insider buying and selling activity for Evolent Health
or or view top insider-buying stocks.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $20.16.

How much money does Evolent Health make?

Evolent Health has a market capitalization of $1.74 billion and generates $846.38 million in revenue each year. The technology company earns $-301,970,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis.

How many employees does Evolent Health have?

Evolent Health employs 2,900 workers across the globe.

What is Evolent Health's official website?

The official website for Evolent Health is www.evolenthealth.com.

Where are Evolent Health's headquarters?

Evolent Health is headquartered at 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000 or via email at [email protected]


This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.